Đang tải…

Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment

Liver resections for hepatocellular carcinoma (HCC) in cirrhotic livers are associated with early recurrence and poor survival. Somatostatin analogues (SSAs) have been reported to inhibit cell proliferation by interacting with specific somatostatin receptors (SSTRs) 2 and 5. The present study invest...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: LIU, YAO, JIANG, LI, MU, YI
Định dạng: Online Bài viết Texto
Ngôn ngữ:English
Được phát hành: D.A. Spandidos 2013
Những chủ đề:
Truy cập trực tuyến:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789087/
https://www.ncbi.nlm.nih.gov/pubmed/24137418
http://dx.doi.org/10.3892/ol.2013.1435